H.R. 2276 · 112th Congress

To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Stage
In committee
Sponsor
Debbie Wasserman Schultz
Introduced
2011-06-22
Latest action
2011-08-25 · Referred to the Subcommittee on Intellectual Property, Competition and the Internet.

Action history

  1. 2011-08-25Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
  2. 2011-06-22Introduced in House
  3. 2011-06-22Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2011-06-22Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. 2011-06-22Referred to the Subcommittee on Health.